PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Inositol Nicotinate→

Inositol Nicotinate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
6556-11-2
Molecular formula
C42H30N6O12
Molecular weight
810.73 g/mol
Drug class
Nicotinic acid derivativeperipheral vasodilator
Mechanism of action
Acts as an esterified form of nicotinic acid that releases nicotinic acid more slowly. It produces peripheral vasodilatory effects and has been associated with changes in lipid metabolism and microcirculatory function.
Indications / reported uses
  • Symptomatic relief of severe intermittent claudication and Raynaud’s phenomenon in the UK product indication for oral inositol nicotinate.

Sources: https://www.nice.org.uk/guidance/ta223/chapter/3-The-technologies · https://pubchem.ncbi.nlm.nih.gov/compound/Inositol-nicotinate · https://pubmed.ncbi.nlm.nih.gov/14467334/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Inositol Nicotinate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Inositol Nicotinate Permitted Daily Exposure (PDE) report (the Inositol Nicotinate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Inositol Nicotinate Occupational Exposure Limit (OEL) report (the Inositol Nicotinate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.